Geriatrics and gerontology international/Geriatrics & gerontology international · 2013 · 13 citations · 22 references
MedicinePsychiatryAdult PsychiatryMental Health CarePsychiatric AssessmentDepressionDepression AssessmentDepressive DisordersMental IllnessPsychiatric DiagnosisPsychological TestingDepression ScreeningDepression Symptom AssessmentDepression SymptomatologyDepressive Symptom AssessmentDiagnostic Assessment Of DepressionMental State ExaminationPrevalence Of DepressionSubjective Scale
AIM: Depression in Alzheimer's disease (AD) has different clinical manifestations from primary depression of non-demented patients. We designed the present study to explore the following: (i) to determine the clinical characteristics of patients with and without depression according to observational and subjective depression screening scale; and (ii) to examine the depression prevalence rate in patients with AD according to these criteria. METHODS: The Geriatric Depression Scale (GDS, observational scale) and Neuropsychiatry Inventory Depression subscale (NPI-D; subjective scale) were administered to 257 patients with drug-naïve probable AD. The study groups were classified into the three subgroups of "no-depression", GDS depression and NPI-DS (NPI-D significant) depression group, and the clinical characteristics of these subgroups were examined. RESULTS: The NPI-DS depression group showed lower scores on the Korean version of the Mini-Mental State Examination compared with the no-depression group, and higher NPI subdomain scores compared with other groups. The GDS depression group showed higher NPI motor subdomain scores compared with the no-depression group. Depression defined by NPI-DS was the least frequent (10.5%), and NPI-DA (NPI-D any) was the most frequent (56.4%). The prevalence of depression defined by GDS and anti-depressant usage was 30.0% and 16.0% each. The level of agreement between the screening tools determined through the kappa index was from low to moderate. CONCLUSIONS: The present study showed that different depression screening tools revealed a different prevalence and poor concordance rate among depression screening tools. Considering lower cognitive functions and higher BPSD symptoms in the NPI-DS depression group, NPI-DS could be associated with disease severity in AD patients. However, the clinical significance of GDS remains uncertain.
22
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
Functional evaluation : Barthel index
F. I. Mahonery · Medical Entomology and Zoology · 1965 · 12.9K citations
The Neuropsychiatric Inventory
Jeffrey L. Cummings, Michael S. Mega, Kevin F. Gray et al. · Neurology · 1994 · 7.6K citations
Medicine, Psychiatry, Psychology +16
A New Clinical Scale for the Staging of Dementia
Charles P. Hughes, Leonard van den Berg, Warren L. Danziger et al. · The British Journal of Psychiatry · 1982 · 7K citations